S&P 500   3,320.79 (-0.27%)
DOW   29,196.04 (-0.52%)
QQQ   223.28 (-0.04%)
AAPL   316.57 (-0.68%)
FB   221.44 (-0.32%)
MSFT   166.50 (-0.36%)
GOOGL   1,482.25 (+0.18%)
AMZN   1,892.00 (+1.46%)
CGC   24.15 (-2.97%)
NVDA   247.94 (-0.54%)
BABA   222.26 (-2.27%)
MU   58.97 (+2.27%)
GE   11.66 (-1.27%)
TSLA   547.20 (+7.19%)
AMD   51.05 (+0.24%)
T   38.52 (+0.36%)
ACB   2.01 (-5.63%)
F   9.21 (+0.55%)
NFLX   338.11 (-0.46%)
PRI   126.41 (-1.57%)
BAC   34.26 (-1.30%)
DIS   143.56 (-0.53%)
GILD   62.63 (-0.56%)
S&P 500   3,320.79 (-0.27%)
DOW   29,196.04 (-0.52%)
QQQ   223.28 (-0.04%)
AAPL   316.57 (-0.68%)
FB   221.44 (-0.32%)
MSFT   166.50 (-0.36%)
GOOGL   1,482.25 (+0.18%)
AMZN   1,892.00 (+1.46%)
CGC   24.15 (-2.97%)
NVDA   247.94 (-0.54%)
BABA   222.26 (-2.27%)
MU   58.97 (+2.27%)
GE   11.66 (-1.27%)
TSLA   547.20 (+7.19%)
AMD   51.05 (+0.24%)
T   38.52 (+0.36%)
ACB   2.01 (-5.63%)
F   9.21 (+0.55%)
NFLX   338.11 (-0.46%)
PRI   126.41 (-1.57%)
BAC   34.26 (-1.30%)
DIS   143.56 (-0.53%)
GILD   62.63 (-0.56%)
S&P 500   3,320.79 (-0.27%)
DOW   29,196.04 (-0.52%)
QQQ   223.28 (-0.04%)
AAPL   316.57 (-0.68%)
FB   221.44 (-0.32%)
MSFT   166.50 (-0.36%)
GOOGL   1,482.25 (+0.18%)
AMZN   1,892.00 (+1.46%)
CGC   24.15 (-2.97%)
NVDA   247.94 (-0.54%)
BABA   222.26 (-2.27%)
MU   58.97 (+2.27%)
GE   11.66 (-1.27%)
TSLA   547.20 (+7.19%)
AMD   51.05 (+0.24%)
T   38.52 (+0.36%)
ACB   2.01 (-5.63%)
F   9.21 (+0.55%)
NFLX   338.11 (-0.46%)
PRI   126.41 (-1.57%)
BAC   34.26 (-1.30%)
DIS   143.56 (-0.53%)
GILD   62.63 (-0.56%)
S&P 500   3,320.79 (-0.27%)
DOW   29,196.04 (-0.52%)
QQQ   223.28 (-0.04%)
AAPL   316.57 (-0.68%)
FB   221.44 (-0.32%)
MSFT   166.50 (-0.36%)
GOOGL   1,482.25 (+0.18%)
AMZN   1,892.00 (+1.46%)
CGC   24.15 (-2.97%)
NVDA   247.94 (-0.54%)
BABA   222.26 (-2.27%)
MU   58.97 (+2.27%)
GE   11.66 (-1.27%)
TSLA   547.20 (+7.19%)
AMD   51.05 (+0.24%)
T   38.52 (+0.36%)
ACB   2.01 (-5.63%)
F   9.21 (+0.55%)
NFLX   338.11 (-0.46%)
PRI   126.41 (-1.57%)
BAC   34.26 (-1.30%)
DIS   143.56 (-0.53%)
GILD   62.63 (-0.56%)
Log in

NYSE:MMS - MAXIMUS Stock Price, Forecast & News

$74.35
-0.94 (-1.25 %)
(As of 01/21/2020 04:00 PM ET)
Today's Range
$74.17
Now: $74.35
$75.44
50-Day Range
$73.11
MA: $74.47
$75.86
52-Week Range
$68.15
Now: $74.35
$82.02
Volume269,372 shs
Average Volume308,552 shs
Market Capitalization$4.76 billion
P/E Ratio19.99
Dividend Yield1.49%
Beta0.79
MAXIMUS, Inc provides business process services (BPS) to government health and human services programs worldwide. The company's Health Services segment offers various BPS, appeals, and assessments for state, provincial, and national government programs, including Medicaid, Children's Health Insurance Program, Affordable Care Act, Health Insurance British Columbia, Health Assessment Advisory Service contract, and Preadmission Screening and Resident Reviews. Read More…

Industry, Sector and Symbol

Industry Business services, not elsewhere classified
Sub-IndustryData Processing & Outsourced Services
SectorBusiness Services
CUSIP57793310
Phone703-251-8500

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$2.89 billion
Cash Flow$5.05 per share
Book Value$19.56 per share

Profitability

Net Income$240.82 million

Miscellaneous

Employees29,600
Market Cap$4.76 billion
Next Earnings Date2/6/2020 (Estimated)
OptionableOptionable

Receive MMS News and Ratings via Email

Sign-up to receive the latest news and ratings for MMS and its competitors with MarketBeat's FREE daily newsletter.


MAXIMUS (NYSE:MMS) Frequently Asked Questions

What is MAXIMUS's stock symbol?

MAXIMUS trades on the New York Stock Exchange (NYSE) under the ticker symbol "MMS."

How often does MAXIMUS pay dividends? What is the dividend yield for MAXIMUS?

MAXIMUS announced a quarterly dividend on Wednesday, January 8th. Stockholders of record on Friday, February 14th will be given a dividend of $0.28 per share on Friday, February 28th. This represents a $1.12 annualized dividend and a dividend yield of 1.51%. The ex-dividend date is Thursday, February 13th. View MAXIMUS's Dividend History.

How will MAXIMUS's stock buyback program work?

MAXIMUS announced that its board has initiated a share repurchase program on Monday, June 25th 2018, which authorizes the company to repurchase $200,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization authorizes the company to repurchase up to 4.9% of its shares through open market purchases. Shares repurchase programs are typically a sign that the company's management believes its shares are undervalued.

How were MAXIMUS's earnings last quarter?

MAXIMUS, Inc. (NYSE:MMS) announced its quarterly earnings results on Tuesday, November, 19th. The health services provider reported $0.93 EPS for the quarter, missing the Thomson Reuters' consensus estimate of $0.94 by $0.01. The health services provider earned $754.97 million during the quarter, compared to the consensus estimate of $756.40 million. MAXIMUS had a return on equity of 21.09% and a net margin of 8.34%. The company's revenue for the quarter was up 35.2% on a year-over-year basis. During the same quarter last year, the firm posted $0.71 earnings per share. View MAXIMUS's Earnings History.

When is MAXIMUS's next earnings date?

MAXIMUS is scheduled to release their next quarterly earnings announcement on Thursday, February 6th 2020. View Earnings Estimates for MAXIMUS.

What guidance has MAXIMUS issued on next quarter's earnings?

MAXIMUS issued an update on its FY 2020 Pre-Market earnings guidance on Monday, November, 25th. The company provided earnings per share (EPS) guidance of $$3.95-4.15 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $$4.07. The company issued revenue guidance of $$3.15-3.3 billion, compared to the consensus revenue estimate of $$3.17 billion.

What price target have analysts set for MMS?

2 analysts have issued 12 month target prices for MAXIMUS's shares. Their forecasts range from $77.00 to $81.00. On average, they anticipate MAXIMUS's share price to reach $79.00 in the next year. This suggests a possible upside of 6.3% from the stock's current price. View Analyst Price Targets for MAXIMUS.

What is the consensus analysts' recommendation for MAXIMUS?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for MAXIMUS in the last year. There are currently 2 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for MAXIMUS.

Has MAXIMUS been receiving favorable news coverage?

News articles about MMS stock have trended somewhat positive this week, according to InfoTrie Sentiment. InfoTrie ranks the sentiment of press coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. MAXIMUS earned a news impact score of 2.0 on InfoTrie's scale. They also gave news coverage about the health services provider a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the company's share price in the near term. View News Stories for MAXIMUS.

Are investors shorting MAXIMUS?

MAXIMUS saw a increase in short interest during the month of December. As of December 31st, there was short interest totalling 1,670,000 shares, an increase of 6.4% from the December 15th total of 1,570,000 shares. Based on an average daily volume of 393,600 shares, the short-interest ratio is currently 4.2 days. Currently, 2.6% of the shares of the stock are sold short. View MAXIMUS's Current Options Chain.

Who are some of MAXIMUS's key competitors?

What other stocks do shareholders of MAXIMUS own?

Who are MAXIMUS's key executives?

MAXIMUS's management team includes the folowing people:
  • Mr. Bruce L. Caswell, Pres, CEO & Director (Age 52)
  • Mr. Richard A. Montoni, Vice Chairman & Sr. Advisor to the CEO (Age 67)
  • Mr. Richard J. Nadeau, CFO & Treasurer (Age 64)
  • Mr. David R. Francis, Gen. Counsel & Sec. (Age 58)
  • Mr. Mark S. Andrekovich, Chief of Human Capital and Former Pres of Tax & Employer Services (Age 57)

Who are MAXIMUS's major shareholders?

MAXIMUS's stock is owned by a variety of of retail and institutional investors. Top institutional investors include Riverbridge Partners LLC (0.73%), West Coast Financial LLC (0.16%), Assenagon Asset Management S.A. (0.08%), Nisa Investment Advisors LLC (0.06%), Louisiana State Employees Retirement System (0.02%) and Bowling Portfolio Management LLC (0.02%). Company insiders that own MAXIMUS stock include David Francis, Mark Andrekovich, Paul R Lederer, Raymond B Ruddy, Richard A Montoni, Russell A Beliveau and Thomas D Romeo. View Institutional Ownership Trends for MAXIMUS.

Which institutional investors are selling MAXIMUS stock?

MMS stock was sold by a variety of institutional investors in the last quarter, including Riverbridge Partners LLC, Bowling Portfolio Management LLC, Nisa Investment Advisors LLC, State of Alaska Department of Revenue, West Coast Financial LLC and Verus Financial Partners Inc.. Company insiders that have sold MAXIMUS company stock in the last year include David Francis, Paul R Lederer, Raymond B Ruddy, Richard A Montoni, Russell A Beliveau and Thomas D Romeo. View Insider Buying and Selling for MAXIMUS.

Which institutional investors are buying MAXIMUS stock?

MMS stock was purchased by a variety of institutional investors in the last quarter, including Assenagon Asset Management S.A., Zeke Capital Advisors LLC, Private Trust Co. NA, First National Bank of Omaha, Larson Financial Group LLC, Camelot Portfolios LLC, Zurcher Kantonalbank Zurich Cantonalbank and Louisiana State Employees Retirement System. View Insider Buying and Selling for MAXIMUS.

How do I buy shares of MAXIMUS?

Shares of MMS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is MAXIMUS's stock price today?

One share of MMS stock can currently be purchased for approximately $74.35.

How big of a company is MAXIMUS?

MAXIMUS has a market capitalization of $4.76 billion and generates $2.89 billion in revenue each year. The health services provider earns $240.82 million in net income (profit) each year or $3.72 on an earnings per share basis. MAXIMUS employs 29,600 workers across the globe.View Additional Information About MAXIMUS.

What is MAXIMUS's official website?

The official website for MAXIMUS is http://www.maximus.com/.

How can I contact MAXIMUS?

MAXIMUS's mailing address is 1891 METRO CENTER DRIVE, RESTON VA, 20190. The health services provider can be reached via phone at 703-251-8500 or via email at [email protected]


MarketBeat Community Rating for MAXIMUS (NYSE MMS)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  413 (Vote Outperform)
Underperform Votes:  411 (Vote Underperform)
Total Votes:  824
MarketBeat's community ratings are surveys of what our community members think about MAXIMUS and other stocks. Vote "Outperform" if you believe MMS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MMS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/21/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel